Literature DB >> 32522469

A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

Gregory P Strauss1, Andrea Pelletier-Baldelli2, Katherine Frost Visser3, Elaine F Walker4, Vijay A Mittal5.   

Abstract

Studies attempting to deconstruct the heterogeneity of schizophrenia and the attenuated psychosis syndrome consistently find that negative symptoms are a core dimension that is distinct from other aspects of the illness (e.g., positive and disorganized symptoms). Negative symptoms are also highly predictive of poor community-based functional outcomes, suggesting they are a critical treatment target. Unfortunately, pharmacological and psychosocial treatments for negative symptoms have demonstrated limited effectiveness. To address this critical unmet therapeutic need, the NIMH sponsored a consensus development conference to delineate research priorities for the field and stimulate treatment development. A primary conclusion of this meeting was that next-generation negative symptom rating scales should be developed to address methodological and conceptual limitations of existing instruments. Although second-generation rating scales were developed for adults with schizophrenia, progress in this area has lagged behind for youth at clinical-high risk (CHR) for developing psychosis (i.e. those meeting criteria for a prodromal syndrome). Given that negative symptoms are highly predictive of the transition to diagnosable psychotic illness, enhancing our ability to detect negative symptoms in CHR youth is paramount. The current paper discusses conceptual and methodological limitations inherent to existing scales that assess negative symptoms in CHR youth. The theoretical and clinical implications of these limitations are evaluated. It is concluded that new scales specifically designed to assess negative symptoms in CHR youth are needed to accurately chart mental illness trajectories and determine when, where, and how to intervene. Recent efforts to develop next-generation measures designed specifically for CHR youth to meet this urgent need in the field are discussed. These new approaches offer significant progress for addressing issues inherent to earlier scales.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alogia; Anhedonia; Asociality; Avolition; Blunted affect; Prodrome

Mesh:

Year:  2020        PMID: 32522469      PMCID: PMC7572550          DOI: 10.1016/j.schres.2020.04.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  80 in total

1.  Recruitment and treatment practices for help-seeking "prodromal" patients.

Authors:  Thomas H McGlashan; Jean Addington; Tyrone Cannon; Markus Heinimaa; Patrick McGorry; Mary O'Brien; David Penn; Diana Perkins; Raimo K R Salokangas; Barbara Walsh; Scott W Woods; Alison Yung
Journal:  Schizophr Bull       Date:  2007-05-04       Impact factor: 9.306

Review 2.  Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept.

Authors:  Frauke Schultze-Lutter
Journal:  Schizophr Bull       Date:  2009-01       Impact factor: 9.306

3.  Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia.

Authors:  Anthony O Ahmed; Brian Kirkpatrick; Silvana Galderisi; Armida Mucci; Alessandro Rossi; Alessandro Bertolino; Paola Rocca; Mario Maj; Stefan Kaiser; Martin Bischof; Matthias N Hartmann-Riemer; Matthias Kirschner; Karoline Schneider; Maria Paz Garcia-Portilla; Anna Mane; Miguel Bernardo; Emilio Fernandez-Egea; Cui Jiefeng; Yao Jing; Tan Shuping; James M Gold; Daniel N Allen; Gregory P Strauss
Journal:  Schizophr Bull       Date:  2019-03-07       Impact factor: 9.306

4.  Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna Lifshey Rosen; Lubna Somjee; Philip J Markovich; Kelly Stein; Scott W Woods
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

5.  Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).

Authors:  William P Horan; Ann M Kring; Raquel E Gur; Steven P Reise; Jack J Blanchard
Journal:  Schizophr Res       Date:  2011-07-27       Impact factor: 4.939

6.  Negative symptoms in youths with psychosis spectrum features: complementary scales in relation to neurocognitive performance and function.

Authors:  Raquel E Gur; Mary March; Monica E Calkins; Lauren Weittenhiller; Daniel H Wolf; Bruce I Turetsky; Ruben C Gur
Journal:  Schizophr Res       Date:  2015-06-17       Impact factor: 4.939

7.  Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.

Authors:  Eva Velthorst; Dorien H Nieman; Hiske E Becker; Reinaud van de Fliert; Peter M Dingemans; Rianne Klaassen; Lieuwe de Haan; Thérèse van Amelsvoort; Don H Linszen
Journal:  Schizophr Res       Date:  2009-03-09       Impact factor: 4.939

Review 8.  A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.

Authors:  Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

9.  The Latent Structure of Negative Symptoms in Schizophrenia.

Authors:  Gregory P Strauss; Alicia Nuñez; Anthony O Ahmed; Kimberly A Barchard; Eric Granholm; Brian Kirkpatrick; James M Gold; Daniel N Allen
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

10.  Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.

Authors:  Joshua A Salomon; Theo Vos; Daniel R Hogan; Michael Gagnon; Mohsen Naghavi; Ali Mokdad; Nazma Begum; Razibuzzaman Shah; Muhammad Karyana; Soewarta Kosen; Mario Reyna Farje; Gilberto Moncada; Arup Dutta; Sunil Sazawal; Andrew Dyer; Jason Seiler; Victor Aboyans; Lesley Baker; Amanda Baxter; Emelia J Benjamin; Kavi Bhalla; Aref Bin Abdulhak; Fiona Blyth; Rupert Bourne; Tasanee Braithwaite; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Rachelle Buchbinder; Peter Burney; Bianca Calabria; Honglei Chen; Sumeet S Chugh; Rebecca Cooley; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Adrian Davis; Louisa Degenhardt; Cesar Díaz-Torné; E Ray Dorsey; Tim Driscoll; Karen Edmond; Alexis Elbaz; Majid Ezzati; Valery Feigin; Cleusa P Ferri; Abraham D Flaxman; Louise Flood; Marlene Fransen; Kana Fuse; Belinda J Gabbe; Richard F Gillum; Juanita Haagsma; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Abdullah Hel-Baqui; Hans W Hoek; Howard Hoffman; Emily Hogeland; Damian Hoy; Deborah Jarvis; Ganesan Karthikeyan; Lisa Marie Knowlton; Tim Lathlean; Janet L Leasher; Stephen S Lim; Steven E Lipshultz; Alan D Lopez; Rafael Lozano; Ronan Lyons; Reza Malekzadeh; Wagner Marcenes; Lyn March; David J Margolis; Neil McGill; John McGrath; George A Mensah; Ana-Claire Meyer; Catherine Michaud; Andrew Moran; Rintaro Mori; Michele E Murdoch; Luigi Naldi; Charles R Newton; Rosana Norman; Saad B Omer; Richard Osborne; Neil Pearce; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Farshad Pourmalek; Martin Prince; Jürgen T Rehm; Guiseppe Remuzzi; Kathryn Richardson; Robin Room; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Maria Segui-Gomez; Saeid Shahraz; Kenji Shibuya; David Singh; Karen Sliwa; Emma Smith; Isabelle Soerjomataram; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Hugh R Taylor; Imad M Tleyjeh; Marieke J van der Werf; Wendy L Watson; David J Weatherall; Robert Weintraub; Marc G Weisskopf; Harvey Whiteford; James D Wilkinson; Anthony D Woolf; Zhi-Jie Zheng; Christopher J L Murray; Jost B Jonas
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  11 in total

1.  The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains.

Authors:  Wing Chung Chang; Gregory P Strauss; Anthony O Ahmed; Sandra C Y Wong; Joe K N Chan; Edwin H M Lee; Sherry K W Chan; Christy L M Hui; Sydney H James; Hannah C Chapman; Eric Y H Chen
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

2.  Genuine and non-genuine smiles in individuals meeting criteria for a clinical high-risk syndrome.

Authors:  Jordyn R Ricard; Tina Gupta; Teresa Vargas; Claudia M Haase; Vijay A Mittal
Journal:  Early Interv Psychiatry       Date:  2021-11-01       Impact factor: 2.721

3.  Commentary. Toward a core outcomes assessment set for clinical high risk.

Authors:  Scott W Woods; Catalina V Mourgues-Codern; Albert R Powers
Journal:  Schizophr Res       Date:  2020-05-12       Impact factor: 4.939

4.  Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial.

Authors:  David J Miklowitz; Jean M Addington; Mary P O'Brien; Danielle M Denenny; Marc J Weintraub; Jamie L Zinberg; Daniel H Mathalon; Barbara A Cornblatt; Michelle S Friedman-Yakoobian; William S Stone; Kristin S Cadenhead; Scott W Woods; Catherine A Sugar; Tyrone D Cannon; Carrie E Bearden
Journal:  Early Interv Psychiatry       Date:  2021-08-23       Impact factor: 2.721

5.  Relations Among Anhedonia, Reinforcement Learning, and Global Functioning in Help-seeking Youth.

Authors:  LeeAnn Akouri-Shan; Jason Schiffman; Zachary B Millman; Caroline Demro; John Fitzgerald; Pamela J Rakhshan Rouhakhtar; Samantha Redman; Gloria M Reeves; Shuo Chen; James M Gold; Elizabeth A Martin; Cheryl Corcoran; Jonathan P Roiser; Robert W Buchanan; Laura M Rowland; James A Waltz
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

6.  The Relationship between PID-5 Personality Traits and Mental States. A Study on a Group of Young Adults at Risk of Psychotic Onset.

Authors:  Maria Meliante; Chiara Rossi; Lara Malvini; Clara Niccoli; Osmano Oasi; Simona Barbera; Mauro Percudani
Journal:  Medicina (Kaunas)       Date:  2021-01-01       Impact factor: 2.430

7.  Secondary Sources of Negative Symptoms in Those Meeting Criteria for a Clinical High-Risk Syndrome.

Authors:  Tina Gupta; Gregory P Strauss; Henry R Cowan; Andrea Pelletier-Baldelli; Lauren M Ellman; Jason Schiffman; Vijay A Mittal
Journal:  Biol Psychiatry Glob Open Sci       Date:  2021-06-02

8.  Computerized Assessment of Psychosis Risk.

Authors:  Vijay A Mittal; Lauren M Ellman; Gregory P Strauss; Elaine F Walker; Philip R Corlett; Jason Schiffman; Scott W Woods; Albert R Powers; Steven M Silverstein; James A Waltz; Richard Zinbarg; Shuo Chen; Trevor Williams; Joshua Kenney; James M Gold
Journal:  J Psychiatr Brain Sci       Date:  2021-06-29

9.  Social functioning and brain imaging in individuals at clinical high-risk for psychosis: A systematic review.

Authors:  Paul D Metzak; Megan S Farris; Thea Placsko; Amy Braun; Dominique Bonneville; Kali Brummitt; Monica Chu; Jean Addington
Journal:  Schizophr Res       Date:  2021-06-11       Impact factor: 4.662

10.  Eveningness chronotype preference among individuals at clinical high risk for psychosis.

Authors:  Jessica R Lunsford-Avery; Andrea Pelletier-Baldelli; Stephanie A Korenic; Jason Schiffman; Lauren M Ellman; Leah Jackson; Vijay A Mittal
Journal:  Schizophr Res       Date:  2021-08-04       Impact factor: 4.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.